Sustainable pharmaceutical manufacturing is not limited to adding renewable energy or reducing waste at the end of a process. It also depends on decisions made earlier: how a facility is designed, how much capacity it needs, which process technologies it uses, and how utilities and water flows are managed. For automation engineers, system integrators and plant leaders, these choices connect environmental performance with operational efficiency and facility lifecycle costs.
Smaller, more controllable production systems and data-based technologies are changing the scale at which pharmaceutical operations can be designed. At the same time, water remains a critical resource, with manufacturing, utilities and wastewater treatment all contributing to site demand and cost. A practical sustainability strategy considers the entire system rather than treating each utility or process area in isolation.
Sustainable pharmaceutical manufacturing starts with facility design
Facility size has a direct influence on the infrastructure needed to support production. The transition from large fixed stainless-steel plants toward smaller facilities using single-use technology has given manufacturers more flexibility in how they configure production. In the example described by Amgen’s facilities representative, a Singapore biologics plant designed around single-use systems occupied about one-quarter of the space of other facilities producing a similar volume of drug substance.
A smaller production footprint can also mean smaller supporting systems. The facility’s purified-water system and steam-in-place capability, for example, can be sized to match actual process requirements. Heating, ventilation and air-conditioning (HVAC), boilers and other utilities should likewise be designed around the facility’s needs and operating conditions—not automatically scaled to a conventional template.
The same representative reported that, compared with a stainless-steel facility producing a similar amount of product, the Singapore plant used 69% less energy, consumed 45% less water and emitted 69% less carbon dioxide. These figures describe that specific comparison; they are not a universal performance guarantee for single-use manufacturing. They illustrate why right-sizing the building and its utilities should be part of early design decisions.
Use process data to improve resource efficiency
Data-based technologies and increased process control can support more efficient facility operation. Continuous manufacturing and processing are associated with smaller, more technologically controllable facilities and may offer potential for increased throughput with a reduced footprint. The practical value depends on how well the process, equipment and supporting infrastructure work together.
For project and operations teams, sustainability should therefore be considered alongside process capability and production objectives. Engineers can assess whether the proposed facility scale matches the manufacturing model, whether utility systems are sized appropriately, and where process monitoring can help reveal unnecessary consumption. These questions are relevant during new construction, renovation and operational review.
Design teams should also consider local conditions. Climate affects HVAC requirements, while local infrastructure and regulations influence water sourcing, treatment and discharge. A solution appropriate for one site may not be suitable elsewhere. Regional requirements and actual operating needs should inform equipment selection and design assumptions.
Make water use visible across the plant
Water efficiency is a significant part of pharmaceutical sustainability because water is used both in production and in supporting utilities. Boilers and cooling systems can be major consumers, while purified-water production and process operations may also generate reject streams or wastewater. Understanding where water enters the facility, how it is used, and where it leaves is a useful first step before selecting conservation measures.
A site assessment can map water flows and identify the quality and destination of discharged streams. It can also examine the costs associated with incoming water, treatment, sewer services and wastewater permits. This picture helps teams distinguish between water that must meet a pharmaceutical process requirement and water that could serve a lower-grade application.
Potential measures described for pharmaceutical facilities include:
- Reuse suitable water in utilities. Recovered water may be appropriate for cooling-tower makeup or boiler feed, depending on its quality and the application.
- Collect clean condensate. Condensate from HVAC cooling coils can be recovered for reuse, rather than discharged.
- Review treatment-system reject streams. Some reverse-osmosis reject water may be suitable for other uses after its quality and system requirements are evaluated.
- Consider gray-water applications. Treated water may be reused for nonproduction purposes such as irrigation or sanitary applications where appropriate.
Water reuse does not necessarily mean returning every stream to product use. The appropriate destination depends on water quality, process needs and applicable requirements. In some locations, limited municipal water or wastewater infrastructure makes water management a necessity as well as an environmental priority.
Set realistic goals for water recovery
Zero liquid discharge (ZLD) is a closed-loop approach intended to minimize or eliminate liquid effluent by treating and recycling wastewater, leaving a solid residue for recovery or disposal. It can be a long-term objective where the investment and site conditions make it appropriate. Facilities can also make progress through staged measures that reduce discharge without immediately implementing a complete ZLD system.
Begin by establishing a baseline: identify water sources, major users, discharge points, stream quality and associated treatment or disposal costs. From there, teams can prioritize opportunities based on technical suitability and economic feasibility. This stepwise approach makes water management an engineering decision grounded in site conditions, rather than an abstract sustainability target.
Connect environmental goals with operational decisions
Sustainability in pharmaceutical manufacturing draws on several connected levers: facility design, process technology, utility sizing, water recovery and waste management. A smaller footprint or a recovery system alone does not define performance; each decision needs to fit the product, process, site and applicable requirements. Organizations may also consider environmental assessment methods and renewable energy options as part of broader facility planning.
For plant managers and technical decision-makers, the practical implication is clear: include resource use in the same conversations as capacity, process control and lifecycle cost. Map utility and water flows, size infrastructure to real requirements, and evaluate reuse options according to stream quality and intended application. These steps create a stronger basis for reducing consumption while maintaining the controls and production needs of pharmaceutical operations.